2-Chloropyridine-4-boronic acid → HCID 16661051, compound
Reaction equation
Cl[C:2]1[C:7]2[N:8]=[C:9]([CH3:11])[S:10][C:6]=2[C:5](I)=[CH:4][N:3]=1.[Cl:13][C:14]1[CH:19]=[C:18](B(O)O)[CH:17]=[CH:16][N:15]=1.[NH2:23][C:24]1[N:25]=[C:26]([CH3:29])[S:27][CH:28]=1>>[Cl:13][C:14]1[CH:19]=[C:18]([C:5]2[C:6]3[S:10][C:9]([CH3:11])=[N:8][C:7]=3[C:2]([NH:23][C:24]3[N:25]=[C:26]([CH3:29])[S:27][CH:28]=3)=[N:3][CH:4]=2)[CH:17]=[CH:16][N:15]=1Participants
4
Procedure
The title compound, MS: m/e=374.0 (M+H+), was prepared in accordance with the general method of example 2, step 1 and step 2 from 4-chloro-7-iodo-2-methyl-thiazolo[4,5-c]pyridine (Example B), 2-chloropyridin-4-boronic acid and 4-amino-2-methylthiazole (Example C).
Sources & evidence
- ORD record
- ord-a012eeb3b3c54dafbe056c4684d9f6d4
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07659401B2
Reaction notes
Loading…